Our data suggest, however, that Tregs are a major effector of intratumor glucocorticoid-mediated immunosuppression because loss of Treg GR signaling contributed to a reduction in tumor growth similar to that seen with the loss of tumor Hsd11b1. The gene discussed is HSD11B1; the disease is neoplasm.